The Jemperli Royalty Rumble: GSK's Tesaro Unit Takes AnaptysBio to Court
AnaptysBio's Big Bet: Decoding the ANB033 Play in the High-Stakes World of Rheumatoid Arthritis
AnaptysBio Unleashes Dual Powerhouse: Splitting into Dedicated Immunology and Oncology Ventures